STADA Arzneimittel
GermanyWho owns STADA Arzneimittel?
STADA Arzneimittel is a German Pharma company, now owned by CapVest Partners, which acquired it in 2026 from Cinven and Bain Capital Europe.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Fully exited in 2026 to CapVest Partners.
- ·Average hold across 2 realized cycles: 9 years.
Ownership history
2 ownership periods · co-invest detected · 1 lender on file
Cinven sold STADA to CapVest Partners in 2026 after 9 years.
Bain Capital Europe sold STADA Arzneimittel to CapVest Partners in 2026 after 9 years.
More from Bain Capital Europe Fund IV
Other portfolio companies in the same fund.
US
ItalyMore PE-backed in Pharma
Comparable pharma deals from other GPs.
France
SpainQuestions
Who owns STADA Arzneimittel?
STADA Arzneimittel is now owned by CapVest Partners, which acquired it in 2026 from Cinven and Bain Capital Europe.
When did CapVest Partners acquire STADA Arzneimittel?
CapVest Partners acquired STADA Arzneimittel in 2026, buying from Cinven and Bain Capital Europe.
Who did STADA Arzneimittel sell to?
Cinven and Bain Capital Europe sold STADA Arzneimittel to CapVest Partners in 2026 (Secondary).
Who has owned STADA Arzneimittel over time?
STADA Arzneimittel has been through 3 private-equity ownership periods: Cinven · via Cinven Sixth Fund · 2017–2026 · sold to CapVest Partners · (Secondary); CIC Private Debt · via CM-CIC Debt Fund 2 · 2017–2026; Bain Capital Europe · via Bain Capital Europe Fund IV · 2017–2026 · sold to CapVest Partners · (Secondary).